GILD
Gilead Sciences, Inc. · NASDAQ:GILD
170.33 USD−0.3500 −0.21%
Gilead Sciences, Inc. (NASDAQ:GILD) last traded at 170.33 USD, down 0.21% on the day. Over the past year the stock is up 46.76%. Its 52-week range is 116.88 to 175.65. It is in the Health Technology sector (Biotechnology).
Key statistics
Open169.85
Day range166.38 – 172.61
52-week range116.88 – 175.65
Volume8.86 M
Average volume (10 days)6.90 M
Market cap211.20 B
EPS (TTM)−3.15
Dividend yield1.90%
Beta (1 year)0.0892
Revenue (TTM)31.06 B
Employees17.00 K
Performance
+8.06%1 week
+15.36%1 month
+29.87%3 months
+27.70%6 months
+39.06%Year to date
+46.76%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
- Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
- Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.